Inozyme Pharma, Inc.
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a solu…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Inozyme Pharma, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Inozyme Pharma, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Inozyme Pharma, Inc..